Jun 23, 2020· Comment from The Association for Accessible Medicines (AAM)· FDA-2019-D-5573-0009
Comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2019-D-5573: Technical Considerations for Demonstrating Reliability of Emergency-Use Injectors Submitted under a BLA, NDA or ANDA.